Resources Investment Advisors, Llc. Oncocyte Corp Transaction History

Resources Investment Advisors, Llc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 08, 2019	SELL	$1.59 - $2.51 $7 - $12	-5 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$1.38 - $2.59 $6 - $12	5 New	5 $0
Q3 2018 Nov 07, 2018	SELL	$2.2 - $3.45 $11 - $17	-5 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	5	5 $0

411K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $247M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Resources Investment Advisors, Llc., based on Form 13F filings with the SEC.

Stay updated on Resources Investment Advisors, Llc. with notifications on news.